期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Fas counterattack in cholangiocarcinoma:a mechanism for immune evasion in human hilar cholangiocarcinomas 被引量:6
1
作者 Zi-Yu Li Sheng-Quan Zou Department of General Surgery of Tongji Hospital,Wuhan,430030,Hubei Province,China 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第6期860-863,共4页
AIM: To investigate FasL expression in hilar cholangiocarcinoma tissues and cultured cholangiocarcinoma cells, and to assess its ability to induce apoptosis. METHODS: We studied the expression of FasL by human hilar c... AIM: To investigate FasL expression in hilar cholangiocarcinoma tissues and cultured cholangiocarcinoma cells, and to assess its ability to induce apoptosis. METHODS: We studied the expression of FasL by human hilar cholangiocaroinomas tissues by immunohistochemistry, and the QBC939 cholangiocarcinoma cell line by RT-PCR, immunohistochemistry, and Western Blot. TUNEL and flow cytometry were used to detect apoptotic cells. RESULTS: Prevalent expression of FasL was detected in 39 resected hilar cholangiocarcinoma tissues. TUNEL staining disclosed a high level of cell death among lymphocytes infiltrating FasL positive areas of tumor. FasL mRNA and protein expressions in cholangiocarcinoma cells could induce Jurkat cells. CONCLUSION: Hilar cholangiocarcinomas may elude immunological surveillance by inducing, via Fas/FasL system, the apoptosis of activated lymphocytes. 展开更多
关键词 Immunologic surveillance Apoptosis CHOLANGIOCARCINOMA Culture Techniques Humans Membrane Glycoproteins RNA Messenger Tumor Cells Cultured
下载PDF
Immunological considerations for laboratory staff and COVID-19 biosafety
2
作者 Ambroise Kouame Kintossou Stephanie Villar Zisis Kozlakidis 《Biosafety and Health》 CAS CSCD 2023年第2期108-111,共4页
The vulnerability of healthcare and laboratory to potential infection by the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)virus has thus far been analyzed through the lens of the acute phase of the pan-d... The vulnerability of healthcare and laboratory to potential infection by the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)virus has thus far been analyzed through the lens of the acute phase of the pan-demic,including remote-based work,as well as emergency settings that are different from routine healthcare operations.However,as lockdowns ease and activities return to an identifiable pre-pandemic routine,the safety considerations also require to shift accordingly.As laboratory workers are likely to continue being exposed to unidentified SARS-CoV-2 positive samples through routine blood collection and processing opera-tions,coronavirus disease 2019(COVID-19)might have to be re-considered as an occupational disease within this context.Additionally,as per many such occupational diseases,a surveillance system is implemented for the medium-and long-term.This manuscript presents the views on the possible surveillance scenarios for labora-tory staff,viewed from an immunological and biosafety perspective. 展开更多
关键词 Laboratory staff COVID-19 biosafety Occupational exposure Immunological monitoring Immunological surveillance
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部